共 50 条
- [1] Olmesartan medoxomil (OLM) plus amlodipine (AML) is well-tolerated in patients with moderate-to-severe hypertensionJOURNAL OF HYPERTENSION, 2008, 26 : S473 - S473Brommer, P.Laeis, P.Ammentorp, B.Haag, U.
- [2] Olmesartan medoxomil (OLM) plus amlodipine (AML) improves BP goal attainment in moderate-to-severe hypertensive patients not adequately controlled with AML monotherapyJOURNAL OF HYPERTENSION, 2008, 26 : S473 - S473Volpe, M.Laeis, P.Ammentorp, B.Haag, U.
- [3] Olmesartan medoxomil (OLM) plus amlodipine (AML) provides BP-lowering efficacy in moderate-to-severe hypertensive patients (pts) not adequately controlled with AML monotherapyJOURNAL OF HYPERTENSION, 2008, 26 : S473 - S473Volpe, M.Laeis, P.Ammentorp, B.Haag, U.
- [5] OLMESARTAN MEDOXOMIL/AMLODIPINE (OLM/AML) PROVIDES 24-HOUR ANTIHYPERTENSIVE EFFICACY - ADDITIONAL EFFECT BY UPTITRATION IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSIONJOURNAL OF HYPERTENSION, 2009, 27 : S283 - S283Heagerty, A. M.Laeis, P.Haag, U.
- [6] BLOOD PRESSURE (BP) THRESHOLD ATTAINMENT WITH OLMESARTAN MEDOXOMIL/AMLODIPINE (OLM/AML) IN PATIENTS WITH MODERATE TO SEVERE HYPERTENSIONJOURNAL OF HYPERTENSION, 2009, 27 : S281 - S282Burnier, M.Mourad, J-J.Koch, W.
- [7] Olmesartan medoxomil (OLM) plus amlodipine (AML) provides BP reduction and improves BP goal rate attainment in patients (pts) with moderate-to-severe hypertensionJOURNAL OF HYPERTENSION, 2008, 26 : S472 - S473Barrios, V.Laies, P.Ammentorp, B.Haag, U.Calderon, A.Escobar, C.
- [10] Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patientsJournal of Human Hypertension, 2011, 25 : 354 - 363R E SchmiederM Böhm